Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
Krug, Lee M, Dr, Kindler, Hedy L, Prof, Calvert, Hilary, MD, Manegold, Christian, Prof, Tsao, Anne S, MD, Fennell, Dean, Prof, Öhman, Ronny, MD, Plummer, Ruth, Prof, Eberhardt, Wilfried E E, MD, Fukuoka, Kazuya, MD, Gaafar, Rabab M, Prof, Lafitte, Jean-Jacques, Prof, Hillerdal, Gunnar, MD, Chu, Quincy, MD, Buikhuisen, Wieneke A, MD, Lubiniecki, Gregory M, MD, Sun, Xing, PhD, Smith, Margaret, BA, Baas, Paul, Prof
Published in The lancet oncology (01.04.2015)
Published in The lancet oncology (01.04.2015)
Get full text
Journal Article